• Tyra Biosciences Reports Second Quarter 2022 Financial Results and Highlights

    9 days ago - By San Diego Biotechnology

    IND clearance received from FDA to proceed with SURF301 Study of TYRA-300-Pipeline on track; IND for TYRA-200 to be filed in 2H 2022-Well-capitalized with cash and cash equivalents of $275.1 million as of...
    Read more ...

     

  • Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(4)

    9 days ago - By San Diego Biotechnology

    SAN DIEGO, Aug. 4, 2022 /PRNewswire/ - Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, today announced that the company granted equity awards to 56 new employees with a grant date of August...
    Read more ...

     

  • QuidelOrtho Reports Second Quarter 2022 Financial Results

    9 days ago - By San Diego Biotechnology

    SAN DIEGO--QuidelOrtho Corporation , a leading in vitro diagnostics company, today announced financial results for the second quarter ended July 3, 2022. The Company reported total revenue for the...
    Read more ...